Mass Spectrometry: An Emerging Path for Clinical Diagnostics
As diagnostics come to depend on increasingly sophisticated knowledge of biomarkers, mass spec emerges as a tool with revolutionary potential.
Read More
Search Results for: lung cancer
Provista Validates Radient Pharmaceuticals’ Onko-Sure Test
Radient Pharmaceuticals Corp announced diagnostics development and commercialization firm Provista Life Sciences LLC (PLS) has independently validated Radient Pharmaceuticals’ Onko-Sure in vitro diagnostic (IVD) cancer test.
Read More
One and Only
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read MoreClovis Oncology, Ventana to Develop Companion Diagnostic Test for CO-101
Clovis Oncology Inc and Ventana Medical Systems Inc announced that they have entered into a collaboration agreement for the development of a human equilibrative nucleoside transporter 1 (hENT1) immunohistochemistry (IHC) assay.
Read MoreRadient Pharmaceuticals Expands Onko-Sure Commercialization
Through its US-based subsidiary AMDL Diagnostics Inc, Radient Pharmaceuticals Corp announced that it plans to expand its worldwide commercialization strategy for its Onko-Sure in vitro diagnostic cancer test to include CLIA laboratory testing services.
Read More